Home/Filings/4/0001144204-18-039049
4//SEC Filing

BFI Co., LLC 4

Accession 0001144204-18-039049

CIK 0001069899other

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 9:02 PM ET

Size

12.8 KB

Accession

0001144204-18-039049

Insider Transaction Report

Form 4
Period: 2018-07-17
BFI Co., LLC
10% Owner
Transactions
  • Sale

    Class A Common Stock

    2018-07-17$48.20/sh9,470$456,45438,000 total
  • Sale

    Class A Common Stock

    2018-07-18$47.95/sh4,000$191,80034,000 total
  • Conversion

    Class A Common Stock

    2018-07-17+17,47047,470 total
  • Sale

    Class A Common Stock

    2018-07-19$47.22/sh4,000$188,88030,000 total
  • Conversion

    Class B Common Stock

    2018-07-1717,47020,318,034 total
    Exercise: $0.00Class A Common Stock (17,470 underlying)
Footnotes (5)
  • [F1]Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.95 to $48.50,inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.75 to $48.40, inclusive.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.10 to $47.40, inclusive.

Issuer

PHIBRO ANIMAL HEALTH CORP

CIK 0001069899

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001601607

Filing Metadata

Form type
4
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 9:02 PM ET
Size
12.8 KB